Keyphrases
Ablation
50%
Adaptation
50%
Antibiotics
100%
Anticancer Therapy
50%
Bacterial SOS Response
50%
Combination Treatment
50%
Cured Patients
50%
DNA Polymerase
50%
DNA Replication
100%
Drug Offers
100%
Drug Resistance Strategies
100%
Drug-tolerant Persister Cells
50%
Drug-tolerant Persisters
50%
Drug-treated
50%
EGFR Inhibitors
100%
EGFR mutation
50%
EGFR-mutant Lung Cancer
100%
Error-prone
100%
Hypermutator
100%
Kinase Inhibitor
50%
Lung Cancer Treatment
50%
Metabolomics
50%
Mutagenesis
50%
Mutator
100%
Neddylation
50%
New Treatment Options
50%
Offering Strategy
100%
Overexpression
50%
Patient-derived Xenograft
50%
Purine Synthesis
50%
Pyrimidine
50%
RAD18
50%
Residual Disease
50%
Resistant Cells
100%
Secondary mutation
50%
SOS Response
50%
T790M
50%
Tumor
50%
Xenograft Model
50%
Medicine and Dentistry
Antibiotics
66%
Cancer Treatment
33%
DNA Polymerase
33%
DNA Synthesis
100%
Drug Resistance
100%
EGFR Inhibitors
66%
Epidermal Growth Factor Receptor
100%
Ethinylestradiol Plus Norethisterone Acetate
100%
Lung Cancer
100%
Metabolomics
33%
Minimal Residual Disease
33%
Mutagenesis
33%
Mutagenic Agent
66%
Neddylation
33%
Neoplasm
33%
Phosphotransferase Inhibitor
33%
Purine Synthesis
33%
Receptor
33%
SOS Response
66%
Treatment of Lung Cancer
33%
Upregulation
33%
Xenograft
66%
Biochemistry, Genetics and Molecular Biology
Anticancer
20%
DNA Polymerase
20%
DNA Synthesis
100%
Drug Resistance
100%
Epidermal Growth Factor Receptor
100%
GAS6
40%
Kinase
20%
Metabolomics
20%
Mutagenesis
20%
Neddylation
20%
Phosphotransferase
20%
Purine Synthesis
20%
Upregulation
20%